Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$5.24 - $6.34 $99,560 - $120,460
-19,000 Reduced 14.9%
108,500 $657,000
Q4 2023

Jan 30, 2024

SELL
$3.36 - $6.21 $71,568 - $132,273
-21,300 Reduced 14.31%
127,500 $773,000
Q3 2023

Oct 26, 2023

SELL
$2.76 - $4.59 $122,543 - $203,796
-44,400 Reduced 22.98%
148,800 $627,000
Q2 2023

Jul 31, 2023

SELL
$1.33 - $3.1 $39,900 - $93,000
-30,000 Reduced 13.44%
193,200 $598,000
Q1 2023

Aug 02, 2023

BUY
$1.27 - $2.7 $38,100 - $81,000
30,000 Added 15.53%
223,200 $310,000
Q4 2022

Jan 26, 2023

SELL
$1.96 - $2.61 $61,740 - $82,215
-31,500 Reduced 12.37%
223,200 $444,000
Q3 2022

Oct 27, 2022

BUY
$2.02 - $3.62 $121,806 - $218,286
60,300 Added 31.02%
254,700 $514,000
Q2 2022

Jul 25, 2022

BUY
$3.01 - $4.46 $46,655 - $69,130
15,500 Added 8.66%
194,400 $618,000
Q1 2022

Apr 21, 2022

SELL
$3.9 - $4.89 $50,310 - $63,080
-12,900 Reduced 6.73%
178,900 $746,000
Q4 2021

Jan 24, 2022

BUY
$3.95 - $5.85 $127,585 - $188,955
32,300 Added 20.25%
191,800 $918,000
Q3 2021

Oct 22, 2021

BUY
$4.31 - $5.64 $15,515 - $20,304
3,600 Added 2.31%
159,500 $851,000
Q2 2021

Jul 26, 2021

BUY
$5.12 - $6.82 $136,192 - $181,412
26,600 Added 20.57%
155,900 $798,000
Q1 2021

Apr 23, 2021

SELL
$4.74 - $7.38 $114,234 - $177,858
-24,100 Reduced 15.71%
129,300 $870,000
Q4 2020

Jan 25, 2021

BUY
$3.95 - $5.42 $36,735 - $50,406
9,300 Added 6.45%
153,400 $701,000
Q3 2020

Dec 14, 2020

BUY
$3.54 - $5.27 $101,244 - $150,722
28,600 Added 24.76%
144,100 $559,000
Q2 2020

Jul 23, 2020

SELL
$2.87 - $5.46 $60,270 - $114,660
-21,000 Reduced 15.38%
115,500 $549,000
Q4 2019

Jan 24, 2020

SELL
$2.65 - $5.56 $124,285 - $260,763
-46,900 Reduced 25.57%
136,500 $657,000
Q3 2019

Oct 21, 2019

BUY
$2.29 - $7.1 $362,278 - $1.12 Million
158,200 Added 627.78%
183,400 $531,000
Q2 2019

Jul 25, 2019

BUY
$6.44 - $14.29 $11,592 - $25,722
1,800 Added 7.69%
25,200 $180,000
Q3 2018

Oct 19, 2018

SELL
$16.4 - $24.27 $32,800 - $48,540
-2,000 Reduced 7.87%
23,400 $519,000
Q2 2018

Aug 06, 2018

BUY
$13.95 - $20.2 $354,330 - $513,080
25,400 New
25,400 $416,000

Others Institutions Holding AMRX

About Amneal Pharmaceuticals, Inc.


  • Ticker AMRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 151,408,992
  • Market Cap $1.26B
  • Description
  • Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...
More about AMRX
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.